Literature DB >> 27815069

MicroRNA-542-3p inhibits the growth of hepatocellular carcinoma cells by targeting FZD7/Wnt signaling pathway.

Wenhua Wu1, Shuangsuo Dang2, Qinhui Feng3, Junrong Liang4, Yuan Wang1, Na Fan5.   

Abstract

MicroRNAs (miRNA) are relevant regulators of the tumorigenesis of various cancers, such as hepatocellular carcinoma (HCC). Recent studies have suggested that miR-542-3p is a tumor suppressor gene in numerous cancers. However, the role of miR-542-3p in HCC remains unclear. This study showed that miR-542-3p was downregulated in HCC tissues and cell lines. MTT, colony formation, and cell cycle assays revealed that miR-542-3p overexpression inhibited HCC cell growth, whereas miR-542-3p suppression promoted cell growth. Frizzled7 (FZD7), the most important Wnt receptor involved in cancer development and progression, was identified as a functional target of miR-542-3p through dual-luciferase reporter assay, RT-qPCR, and Western blot. The mRNA expression of FZD7 was inversely correlated with miR-542-3p expression in HCC tissues. miR-542-3p overexpression could significantly decrease the activation of Wnt signaling pathway in HCC cells. FZD7 overexpression could significantly reverse the inhibitory effect of miR-542-3p on HCC cell growth and Wnt signaling pathway. Taken together, our study suggests that miR-542-3p inhibits HCC cell growth by targeting FZD7 and inhibiting Wnt signaling pathway. The decreased miR-542-3p expression may also contribute to the progression of HCC and may represent a novel molecular therapeutic target for HCC.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FZD7; Hepatocellular carcinoma; Wnt signaling pathway; miR-542-3p

Mesh:

Substances:

Year:  2016        PMID: 27815069     DOI: 10.1016/j.bbrc.2016.10.136

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development.

Authors:  Nuobei Zhang; Xin Chen
Journal:  Cell Oncol (Dordr)       Date:  2019-11-05       Impact factor: 6.730

Review 2.  Circular RNAs: Functions and Prospects in Glioma.

Authors:  Zheng Hao; Si Hu; Zheng Liu; Weixin Song; Yeyu Zhao; Meihua Li
Journal:  J Mol Neurosci       Date:  2018-11-20       Impact factor: 3.444

Review 3.  Spectrum of microRNAs and their target genes in cancer: intervention in diagnosis and therapy.

Authors:  Alti Dayakar; Kumar D Shanmukha; Suresh K Kalangi
Journal:  Mol Biol Rep       Date:  2022-01-15       Impact factor: 2.742

4.  MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression.

Authors:  Kristoffer Unterbruner; Frank Matthes; Judith Schilling; Rohit Nalavade; Stephanie Weber; Jennifer Winter; Sybille Krauß
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

Review 5.  Deregulation of Frizzled Receptors in Hepatocellular Carcinoma.

Authors:  Kristy Kwan-Shuen Chan; Regina Cheuk-Lam Lo
Journal:  Int J Mol Sci       Date:  2018-01-21       Impact factor: 5.923

6.  MicroRNA-542-3p suppresses tumor cell proliferation via targeting Smad2 inhuman osteosarcoma.

Authors:  Yinsheng Wu; Jiongming You; Feng Li; Feng Wang; Yong Wang
Journal:  Oncol Lett       Date:  2018-03-12       Impact factor: 2.967

7.  MicroRNA-192-5p suppresses the initiation and progression of osteosarcoma by targeting USP1.

Authors:  Sheng Zhou; Min Xiong; Guo Dai; Ling Yu; Zhengpei Zhang; Jie Chen; Weichun Guo
Journal:  Oncol Lett       Date:  2018-03-06       Impact factor: 2.967

8.  MicroRNA-542-3p inhibits oral squamous cell carcinoma progression by inhibiting ILK/TGF-β1/Smad2/3 signaling.

Authors:  Bin Qiao; Jing-Hua Cai; Alfred King-Yin Lam; Bao-Xia He
Journal:  Oncotarget       Date:  2017-08-07

9.  The Abnormal Expression of MicroRNA-542-3p in Hepatocellular Carcinoma and Its Clinical Significance.

Authors:  Xi Chen; Qi Zhang; Weijie Ma; Tian Lan; Zhenfei Hong; Yufeng Yuan
Journal:  Dis Markers       Date:  2018-02-11       Impact factor: 3.434

10.  Frizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis.

Authors:  Yinu Wang; Guangyuan Zhao; Salvatore Condello; Hao Huang; Horacio Cardenas; Edward J Tanner; JianJun Wei; Yanrong Ji; Junjie Li; Yuying Tan; Ramana V Davuluri; Marcus E Peter; Ji-Xin Cheng; Daniela Matei
Journal:  Cancer Res       Date:  2020-11-10       Impact factor: 13.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.